{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:22:43Z","timestamp":1792783363954,"version":"4.5.0"},"reference-count":134,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T00:00:00Z","timestamp":1758153600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T00:00:00Z","timestamp":1758153600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82460220"],"award-info":[{"award-number":["82460220"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Natural Science Foundation of Shanghai","award":["21ZR1411700"],"award-info":[{"award-number":["21ZR1411700"]}]},{"DOI":"10.13039\/501100018543","name":"Natural Science Foundation of Tibet Autonomous Region","doi-asserted-by":"publisher","award":["XZ202401ZR0046"],"award-info":[{"award-number":["XZ202401ZR0046"]}],"id":[{"id":"10.13039\/501100018543","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Natural Science Foundation of Shigats","award":["RKZ2023ZR-008(Z)"],"award-info":[{"award-number":["RKZ2023ZR-008(Z)"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clinic Rev Allerg Immunol"],"DOI":"10.1007\/s12016-025-09097-4","type":"journal-article","created":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T09:32:15Z","timestamp":1758187935000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Targeting IL-4\/IL-13 Signaling Pathways in Chronic Rhinosinusitis with Nasal Polyps: From Mechanisms to Therapies"],"prefix":"10.1007","volume":"68","author":[{"given":"Jiani","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianqian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuying","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yizhang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirui","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenwen","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaguang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dehui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xicai","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,18]]},"reference":[{"issue":"2","key":"9097_CR1","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1111\/cea.14065","volume":"52","author":"Y Yao","year":"2022","unstructured":"Yao Y, Zeng M, Liu Z (2022) Revisiting Asian chronic rhinosinusitis in the era of type 2 biologics. Clin Exp Allergy 52(2):231\u2013243. https:\/\/doi.org\/10.1111\/cea.14065","journal-title":"Clin Exp Allergy"},{"issue":"6417","key":"9097_CR2","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/362248a0","volume":"362","author":"A Minty","year":"1993","unstructured":"Minty A et al (1993) Interleukin-13 is a new human lymphokine regulating inflammatory and immune responses. Nature 362(6417):248\u2013250","journal-title":"Nature"},{"issue":"1","key":"9097_CR3","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/0167-5699(94)90021-3","volume":"15","author":"G Zurawski","year":"1994","unstructured":"Zurawski G, de Vries JE (1994) Interleukin 13, an interleukin 4-like cytokine that acts on monocytes and B cells, but not on T cells. Immunol Today 15(1):19\u201326","journal-title":"Immunol Today"},{"issue":"4","key":"9097_CR4","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.cytogfr.2014.07.010","volume":"25","author":"C Ranasinghe","year":"2014","unstructured":"Ranasinghe C et al (2014) IL-4 and IL-13 receptors: roles in immunity and powerful vaccine adjuvants. Cytokine Growth Factor Rev 25(4):437\u2013442. https:\/\/doi.org\/10.1016\/j.cytogfr.2014.07.010","journal-title":"Cytokine Growth Factor Rev"},{"key":"9097_CR5","doi-asserted-by":"publisher","DOI":"10.1002\/alr.23343","author":"M Fieux","year":"2024","unstructured":"Fieux M et al (2024) Dupilumab prevents nasal epithelial function alteration by IL-4 in vitro: evidence for its efficacy. Int Forum Allergy Rhinol. https:\/\/doi.org\/10.1002\/alr.23343","journal-title":"Int Forum Allergy Rhinol"},{"issue":"2","key":"9097_CR6","doi-asserted-by":"publisher","DOI":"10.4168\/aair.2019.11.2.201","volume":"11","author":"D-K Kim","year":"2019","unstructured":"Kim D-K et al (2019) Comparison between signature cytokines of nasal tissues in subtypes of chronic rhinosinusitis. Allergy Asthma Immunol Res 11(2):201. https:\/\/doi.org\/10.4168\/aair.2019.11.2.201","journal-title":"Allergy Asthma Immunol Res"},{"issue":"5","key":"9097_CR7","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1016\/j.jaci.2020.12.623","volume":"147","author":"H Wang","year":"2021","unstructured":"Wang H et al (2021) Defective STING expression potentiates IL-13 signaling in epithelial cells in eosinophilic chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol 147(5):1692\u20131703. https:\/\/doi.org\/10.1016\/j.jaci.2020.12.623","journal-title":"J Allergy Clin Immunol"},{"key":"9097_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2023.04.013","author":"L Chang","year":"2023","unstructured":"Chang L et al (2023) IL-21 induces pyroptosis of Treg cells via Akt-mTOR-NLRP3-caspase 1 axis in eosinophilic chronic rhinosinusitis. J Allergy Clin Immunol. https:\/\/doi.org\/10.1016\/j.jaci.2023.04.013","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"9097_CR9","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1016\/j.jaci.2023.11.922","volume":"153","author":"R Harmon","year":"2024","unstructured":"Harmon R et al (2024) IL-13 and IL-13-induced periostin levels are specifically decreased in patients following endoscopic sinus surgery for chronic rhinosinusitis. J Allergy Clin Immunol 153(5):1292\u20131305. https:\/\/doi.org\/10.1016\/j.jaci.2023.11.922","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"9097_CR10","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.jaci.2016.07.020","volume":"139","author":"JY Min","year":"2017","unstructured":"Min JY et al (2017) Proton pump inhibitors decrease eotaxin-3\/CCL26 expression in patients with chronic rhinosinusitis with nasal polyps: possible role of the nongastric H,K-ATPase. J Allergy Clin Immunol 139(1):130-141.e11. https:\/\/doi.org\/10.1016\/j.jaci.2016.07.020","journal-title":"J Allergy Clin Immunol"},{"key":"9097_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02330","author":"YJ Jang","year":"2018","unstructured":"Jang YJ et al (2018) Enhanced interferon-\u03b2 response contributes to eosinophilic chronic rhinosinusitis. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2018.02330","journal-title":"Front Immunol"},{"issue":"5","key":"9097_CR12","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1111\/cea.12287","volume":"44","author":"S Baba","year":"2014","unstructured":"Baba S et al (2014) Local increase in IgE and class switch recombination to IgE in nasal polyps in chronic rhinosinusitis. Clin Exp Allergy 44(5):701\u2013712. https:\/\/doi.org\/10.1111\/cea.12287","journal-title":"Clin Exp Allergy"},{"issue":"4","key":"9097_CR13","first-page":"1103","volume":"62","author":"SO Rahaman","year":"2002","unstructured":"Rahaman SO et al (2002) IL-13R(alpha)2, a decoy receptor for IL-13 acts as an inhibitor of IL-4-dependent signal transduction in glioblastoma cells. Can Res 62(4):1103\u20131109","journal-title":"Can Res"},{"issue":"10","key":"9097_CR14","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1093\/neuonc\/nou045","volume":"16","author":"B Thaci","year":"2014","unstructured":"Thaci B et al (2014) Significance of interleukin-13 receptor alpha 2-targeted glioblastoma therapy. Neuro Oncol 16(10):1304\u20131312. https:\/\/doi.org\/10.1093\/neuonc\/nou045","journal-title":"Neuro Oncol"},{"key":"9097_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.cytogfr.2016.04.002","author":"Z Ul-Haq","year":"2016","unstructured":"Ul-Haq Z, Naz S, Mesaik MA (2016) Interleukin-4 receptor signaling and its binding mechanism: a therapeutic insight from inhibitors tool box. Cytokine Growth Factor Rev. https:\/\/doi.org\/10.1016\/j.cytogfr.2016.04.002","journal-title":"Cytokine Growth Factor Rev"},{"issue":"6","key":"9097_CR16","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1067\/mai.2000.107604","volume":"105","author":"H Jiang","year":"2000","unstructured":"Jiang H, Harris MB, Rothman P (2000) IL-4\/IL-13 signaling beyond JAK\/STAT. J Aller Clin Immunol 105(6):1063\u20131070. https:\/\/doi.org\/10.1067\/mai.2000.107604","journal-title":"J Aller Clin Immunol"},{"issue":"2","key":"9097_CR17","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.cell.2007.12.030","volume":"132","author":"SL Laporte","year":"2008","unstructured":"Laporte SL et al (2008) Molecular and structural basis of cytokine receptor pleiotropy in the interleukin-4\/13 system. Cell 132(2):259\u2013272. https:\/\/doi.org\/10.1016\/j.cell.2007.12.030","journal-title":"Cell"},{"issue":"1","key":"9097_CR18","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1111\/all.13489","volume":"74","author":"Y Zhang","year":"2019","unstructured":"Zhang Y et al (2019) Th2 cytokines orchestrate the secretion of MUC5AC and MUC5B in IL-5-positive chronic rhinosinusitis with nasal polyps. Allergy 74(1):131\u2013140. https:\/\/doi.org\/10.1111\/all.13489","journal-title":"Allergy"},{"issue":"2","key":"9097_CR19","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1165\/rcmb.2003-0071OC","volume":"30","author":"JW Steinke","year":"2004","unstructured":"Steinke JW et al (2004) Characterization of interleukin-4-stimulated nasal polyp fibroblasts. Am J Respir Cell Mol Biol 30(2):212\u2013219","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"5","key":"9097_CR20","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1111\/all.14151","volume":"75","author":"A Le Floc\u2019h","year":"2020","unstructured":"Le Floc\u2019h A et al (2020) Dual blockade of IL-4 and IL-13 with dupilumab, an IL-4Ralpha antibody, is required to broadly inhibit type 2 inflammation. Allergy 75(5):1188\u20131204. https:\/\/doi.org\/10.1111\/all.14151","journal-title":"Allergy"},{"issue":"5","key":"9097_CR21","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1189\/jlb.0306209","volume":"81","author":"C Ratth\u00e9","year":"2007","unstructured":"Ratth\u00e9 C et al (2007) Molecular mechanisms involved in interleukin-4-induced human neutrophils: expression and regulation of suppressor of cytokine signaling. J Leukoc Biol 81(5):1287\u20131296. https:\/\/doi.org\/10.1189\/jlb.0306209","journal-title":"J Leukoc Biol"},{"issue":"4","key":"9097_CR22","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1165\/ajrcmb.19.4.3208","volume":"19","author":"GR Dubois","year":"1998","unstructured":"Dubois GR et al (1998) Human eosinophils constitutively express a functional interleukin-4 receptor: interleukin-4-induced priming of chemotactic responses and induction of PI-3 kinase activity. Am J Respir Cell Mol Biol 19(4):691\u2013699","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"9","key":"9097_CR23","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1111\/j.1398-9995.2006.01139.x","volume":"61","author":"D Kaur","year":"2006","unstructured":"Kaur D et al (2006) Mast cells express IL-13R\u03b11: IL-13 promotes human lung mast cell proliferation and Fc\u025bRI expression. Allergy 61(9):1047\u20131053. https:\/\/doi.org\/10.1111\/j.1398-9995.2006.01139.x","journal-title":"Allergy"},{"issue":"6","key":"9097_CR24","doi-asserted-by":"publisher","first-page":"2172","DOI":"10.1182\/blood.V96.6.2172","volume":"96","author":"K Suzuki","year":"2000","unstructured":"Suzuki K et al (2000) Role of common cytokine receptor gamma chain (gamma(c))- and Jak3-dependent signaling in the proliferation and survival of murine mast cells. Blood 96(6):2172\u20132180","journal-title":"Blood"},{"issue":"12","key":"9097_CR25","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1080\/1744666X.2021.1847083","volume":"16","author":"HH Kariyawasam","year":"2020","unstructured":"Kariyawasam HH (2020) Chronic rhinosinusitis with nasal polyps: mechanistic insights from targeting IL-4 and IL-13 via IL-4R\u03b1 inhibition with dupilumab. Expert Rev Clin Immunol 16(12):1115\u20131125. https:\/\/doi.org\/10.1080\/1744666X.2021.1847083","journal-title":"Expert Rev Clin Immunol"},{"key":"9097_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2022.11.029","author":"B-F Wang","year":"2023","unstructured":"Wang B-F et al (2023) Evidence that oncostatin M synergizes with IL-4 signaling to induce TSLP expression in chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol. https:\/\/doi.org\/10.1016\/j.jaci.2022.11.029","journal-title":"J Allergy Clin Immunol"},{"key":"9097_CR27","doi-asserted-by":"publisher","unstructured":"Kanai K et al (2025) Expression of IL-4 receptor alpha in ectopic lymphoid tissue in chronic rhinosinusitis. Allergy. https:\/\/doi.org\/10.1111\/all.16649","DOI":"10.1111\/all.16649"},{"issue":"21","key":"9097_CR28","doi-asserted-by":"publisher","first-page":"3857","DOI":"10.1016\/j.cell.2022.09.023","volume":"185","author":"RL Philips","year":"2022","unstructured":"Philips RL et al (2022) The JAK-STAT pathway at 30: much learned, much more to do. Cell 185(21):3857\u20133876. https:\/\/doi.org\/10.1016\/j.cell.2022.09.023","journal-title":"Cell"},{"issue":"1","key":"9097_CR29","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.cyto.2015.05.023","volume":"75","author":"SM McCormick","year":"2015","unstructured":"McCormick SM, Heller NM (2015) Commentary: IL-4 and IL-13 receptors and signaling. Cytokine 75(1):38\u201350. https:\/\/doi.org\/10.1016\/j.cyto.2015.05.023","journal-title":"Cytokine"},{"key":"9097_CR30","doi-asserted-by":"publisher","DOI":"10.1111\/cea.14484","author":"C Luo","year":"2024","unstructured":"Luo C et al (2024) Increased SERPINB2 potentiates 15LO1 expression via STAT6 signalling in epithelial cells in eosinophilic chronic rhinosinusitis with nasal polyps. Clin Exp Allergy. https:\/\/doi.org\/10.1111\/cea.14484","journal-title":"Clin Exp Allergy"},{"issue":"2","key":"9097_CR31","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.jaci.2022.06.012","volume":"150","author":"A Shankar","year":"2022","unstructured":"Shankar A, McAlees JW, Lewkowich IP (2022) Modulation of IL-4\/IL-13 cytokine signaling in the context of allergic disease. J Allergy Clin Immunol 150(2):266\u2013276. https:\/\/doi.org\/10.1016\/j.jaci.2022.06.012","journal-title":"J Allergy Clin Immunol"},{"issue":"16","key":"9097_CR32","doi-asserted-by":"publisher","first-page":"9898","DOI":"10.1074\/jbc.273.16.9898","volume":"273","author":"HY Wang","year":"1998","unstructured":"Wang HY, Zamorano J, Keegan AD (1998) A role for the insulin-interleukin (IL)-4 receptor motif of the IL-4 receptor \u03b1-chain in regulating activation of the insulin receptor substrate 2 and signal transducer and activator of transcription 6 pathways. J Biol Chem 273(16):9898\u20139905. https:\/\/doi.org\/10.1074\/jbc.273.16.9898","journal-title":"J Biol Chem"},{"issue":"51","key":"9097_CR33","doi-asserted-by":"publisher","first-page":"pe55","DOI":"10.1126\/scisignal.1.51.pe55","volume":"1","author":"M Wills-Karp","year":"2008","unstructured":"Wills-Karp M, Finkelman FD (2008) Untangling the complex web of IL-4\u2013 and IL-13\u2013mediated signaling pathways. Sci Signal 1(51):pe55\u2013pe55. https:\/\/doi.org\/10.1126\/scisignal.1.51.pe55","journal-title":"Sci Signal"},{"issue":"5128","key":"9097_CR34","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1126\/science.8372354","volume":"261","author":"L-M Wang","year":"1993","unstructured":"Wang L-M et al (1993) IRS-1: essential for insulin- and IL-4-stimulated mitogenesis in hematopoietic cells. Science 261(5128):1591\u20131594. https:\/\/doi.org\/10.1126\/science.8372354","journal-title":"Science"},{"issue":"3","key":"9097_CR35","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1096\/fj.05-5045com","volume":"20","author":"KS Lee","year":"2006","unstructured":"Lee KS et al (2006) Inhibition of phosphoinositide 3-kinase delta attenuates allergic airway inflammation and hyperresponsiveness in murine asthma model. FASEB Journal: Official Publication of the Federation of American Societies For Experimental Biology 20(3):455\u2013465","journal-title":"FASEB Journal: Official Publication of the Federation of American Societies For Experimental Biology"},{"issue":"5","key":"9097_CR36","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1124\/mol.108.045419","volume":"73","author":"HSM Farghaly","year":"2008","unstructured":"Farghaly HSM et al (2008) Interleukin 13 increases contractility of murine tracheal smooth muscle by a phosphoinositide 3-kinase p110delta-dependent mechanism. Molecular Pharmacology 73(5):1530\u20131537. https:\/\/doi.org\/10.1124\/mol.108.045419","journal-title":"Molecular Pharmacology"},{"issue":"9","key":"9097_CR37","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/nri3495","volume":"13","author":"JSC Arthur","year":"2013","unstructured":"Arthur JSC, Ley SC (2013) Mitogen-activated protein kinases in innate immunity. Nat Rev Immunol 13(9):679\u2013692. https:\/\/doi.org\/10.1038\/nri3495","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"9097_CR38","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1172\/jci25711","volume":"116","author":"PJ Lee","year":"2005","unstructured":"Lee PJ (2005) ERK1\/2 mitogen-activated protein kinase selectively mediates IL-13-induced lung inflammation and remodeling in vivo. J Clin Invest 116(1):163\u2013173. https:\/\/doi.org\/10.1172\/jci25711","journal-title":"J Clin Invest"},{"issue":"34","key":"9097_CR39","doi-asserted-by":"publisher","first-page":"14246","DOI":"10.1073\/pnas.1018075108","volume":"108","author":"J Zhao","year":"2011","unstructured":"Zhao J et al (2011) 15-lipoxygenase 1 interacts with phosphatidylethanolamine-binding protein to regulate MAPK signaling in human airway epithelial cells. Proc Natl Acad Sci U S A 108(34):14246\u201314251. https:\/\/doi.org\/10.1073\/pnas.1018075108","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"9097_CR40","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1038\/labinvest.2012.67","volume":"92","author":"L Petecchia","year":"2012","unstructured":"Petecchia L et al (2012) Cytokines induce tight junction disassembly in airway cells via an EGFR-dependent MAPK\/ERK1\/2-pathway. Lab Invest 92(8):1140\u20131148. https:\/\/doi.org\/10.1038\/labinvest.2012.67","journal-title":"Lab Invest"},{"issue":"5","key":"9097_CR41","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1016\/j.jaci.2022.12.826","volume":"151","author":"ME Kotas","year":"2023","unstructured":"Kotas ME et al (2023) IL-13\u2013associated epithelial remodeling correlates with clinical severity in nasal polyposis. J Allergy Clin Immunol 151(5):1277\u20131285. https:\/\/doi.org\/10.1016\/j.jaci.2022.12.826","journal-title":"J Allergy Clin Immunol"},{"key":"9097_CR42","doi-asserted-by":"publisher","unstructured":"Xie X et al (2024) Transdifferentiation of epithelial cells and fibroblasts induced by IL-1\u03b2 fuels neutrophil recruitment in chronic rhinosinusitis. https:\/\/doi.org\/10.1101\/2024.01.28.576762","DOI":"10.1101\/2024.01.28.576762"},{"key":"9097_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-52341-8","author":"Y Wang","year":"2024","unstructured":"Wang Y, Li Z, Lu J (2024) Single-cell RNA sequencing reveals the epithelial cell, fibroblast, and key gene alterations in chronic rhinosinusitis with nasal polyps. Sci Rep. https:\/\/doi.org\/10.1038\/s41598-024-52341-8","journal-title":"Sci Rep"},{"issue":"3","key":"9097_CR44","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1111\/cea.12644","volume":"46","author":"J Jiao","year":"2016","unstructured":"Jiao J et al (2016) Role of IFN-\u03b3, IL-13, and IL-17 on mucociliary differentiation of nasal epithelial cells in chronic rhinosinusitis with nasal polyps. Clin Exp Allergy 46(3):449\u2013460. https:\/\/doi.org\/10.1111\/cea.12644","journal-title":"Clin Exp Allergy"},{"issue":"2","key":"9097_CR45","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1111\/all.14699","volume":"76","author":"T Yuan","year":"2021","unstructured":"Yuan T et al (2021) Role of yes-associated protein in interleukin-13 induced nasal remodeling of chronic rhinosinusitis with nasal polyps. Allergy 76(2):600\u2013604. https:\/\/doi.org\/10.1111\/all.14699","journal-title":"Allergy"},{"key":"9097_CR46","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.159832","author":"ME Kotas","year":"2022","unstructured":"Kotas ME et al (2022) IL-13-programmed airway tuft cells produce PGE2, which promotes CFTR-dependent mucociliary function. JCI Insight. https:\/\/doi.org\/10.1172\/jci.insight.159832","journal-title":"JCI Insight"},{"issue":"4","key":"9097_CR47","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.alit.2024.04.001","volume":"73","author":"K Kawakita","year":"2024","unstructured":"Kawakita K et al (2024) Role of basal cells in nasal polyp epithelium in the pathophysiology of eosinophilic chronic rhinosinusitis (eCRS). Allergol Int 73(4):563\u2013572. https:\/\/doi.org\/10.1016\/j.alit.2024.04.001","journal-title":"Allergol Int"},{"key":"9097_CR48","doi-asserted-by":"publisher","DOI":"10.1172\/JCI181995","author":"GS Romano Ibarra","year":"2024","unstructured":"Romano Ibarra GS et al (2024) Il-13 induces loss of CFTR in ionocytes and reduces airway epithelial fluid absorption. J Clin Invest. https:\/\/doi.org\/10.1172\/JCI181995","journal-title":"J Clin Invest"},{"issue":"6","key":"9097_CR49","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1016\/j.jaci.2023.01.030","volume":"151","author":"X Wang","year":"2023","unstructured":"Wang X et al (2023) Type 2 inflammation drives an airway basal stem cell program through insulin receptor substrate signaling. J Allergy Clin Immunol 151(6):1536\u20131549. https:\/\/doi.org\/10.1016\/j.jaci.2023.01.030","journal-title":"J Allergy Clin Immunol"},{"issue":"7","key":"9097_CR50","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1111\/all.15705","volume":"78","author":"HJ Cho","year":"2023","unstructured":"Cho HJ et al (2023) IL-4 drastically decreases deuterosomal and multiciliated cells via alteration in progenitor cell differentiation. Allergy 78(7):1866\u20131877. https:\/\/doi.org\/10.1111\/all.15705","journal-title":"Allergy"},{"key":"9097_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2012.05.052","author":"MB Soyka","year":"2012","unstructured":"Soyka MB et al (2012) Defective epithelial barrier in chronic rhinosinusitis: the regulation of tight junctions by IFN-\u03b3 and IL-4. J Allergy Clin Immunol. https:\/\/doi.org\/10.1016\/j.jaci.2012.05.052","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"9097_CR52","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.jaci.2016.03.050","volume":"139","author":"P Wawrzyniak","year":"2017","unstructured":"Wawrzyniak P et al (2017) Regulation of bronchial epithelial barrier integrity by type 2 cytokines and histone deacetylases in asthmatic patients. J Allergy Clin Immunol 139(1):93\u2013103. https:\/\/doi.org\/10.1016\/j.jaci.2016.03.050","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"9097_CR53","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.jaci.2017.02.038","volume":"141","author":"K Sugita","year":"2018","unstructured":"Sugita K et al (2018) Type 2 innate lymphoid cells disrupt bronchial epithelial barrier integrity by targeting tight junctions through IL-13 in asthmatic patients. J Allergy Clin Immunol 141(1):300-310.e11. https:\/\/doi.org\/10.1016\/j.jaci.2017.02.038","journal-title":"J Allergy Clin Immunol"},{"key":"9097_CR54","doi-asserted-by":"publisher","unstructured":"Steelant B et al (2018) Histamine and T helper cytokine-driven epithelial barrier dysfunction in allergic rhinitis. J Allergy Clin Immunol 141(3):951\u2013963 e8. https:\/\/doi.org\/10.1016\/j.jaci.2017.08.039","DOI":"10.1016\/j.jaci.2017.08.039"},{"issue":"5","key":"9097_CR55","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/alr.21298","volume":"4","author":"SK Wise","year":"2014","unstructured":"Wise SK et al (2014) Interleukin-4 and interleukin-13 compromise the sinonasal epithelial barrier and perturb intercellular junction protein expression. Int Forum Allergy Rhinol 4(5):361\u2013370. https:\/\/doi.org\/10.1002\/alr.21298","journal-title":"Int Forum Allergy Rhinol"},{"issue":"4","key":"9097_CR56","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1111\/cea.14258","volume":"53","author":"S Duan","year":"2023","unstructured":"Duan S et al (2023) Histone deacetylase activity is a novel target for epithelial barrier defects in patients with eosinophilic chronic rhinosinusitis with nasal polyps. Clin Exp Allergy 53(4):443\u2013454. https:\/\/doi.org\/10.1111\/cea.14258","journal-title":"Clin Exp Allergy"},{"key":"9097_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecoenv.2024.116793","volume":"283","author":"X Guo","year":"2024","unstructured":"Guo X et al (2024) Involvement of M2 macrophages polarization in PM2.5-induced COPD by upregulating MMP12 via IL4\/STAT6 pathway. Ecotoxicol Environ Saf 283:116793. https:\/\/doi.org\/10.1016\/j.ecoenv.2024.116793","journal-title":"Ecotoxicol Environ Saf"},{"issue":"2","key":"9097_CR58","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1111\/all.14287","volume":"76","author":"LL Shi","year":"2021","unstructured":"Shi LL et al (2021) Cold-inducible RNA-binding protein contributes to tissue remodeling in chronic rhinosinusitis with nasal polyps. Allergy 76(2):497\u2013509. https:\/\/doi.org\/10.1111\/all.14287","journal-title":"Allergy"},{"issue":"4","key":"9097_CR59","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1172\/jci14136","volume":"110","author":"S Lanone","year":"2002","unstructured":"Lanone S et al (2002) Overlapping and enzyme-specific contributions of matrix metalloproteinases-9 and -12 in IL-13\u2013induced inflammation and remodeling. J Clin Invest 110(4):463\u2013474. https:\/\/doi.org\/10.1172\/jci14136","journal-title":"J Clin Invest"},{"key":"9097_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2010.05.015","author":"SJ Wadsworth","year":"2010","unstructured":"Wadsworth SJ et al (2010) IL-13 and TH2 cytokine exposure triggers matrix metalloproteinase 7-mediated Fas ligand cleavage from bronchial epithelial cells. J Allergy Clin Immunol. https:\/\/doi.org\/10.1016\/j.jaci.2010.05.015","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"9097_CR61","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1165\/rcmb.2014-0290oc","volume":"54","author":"JL Ingram","year":"2016","unstructured":"Ingram JL et al (2016) Role of matrix metalloproteinases-1 and -2 in interleukin-13\u2013suppressed elastin in airway fibroblasts in asthma. Am J Respir Cell Mol Biol 54(1):41\u201350. https:\/\/doi.org\/10.1165\/rcmb.2014-0290oc","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"12","key":"9097_CR62","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1172\/jci13557","volume":"108","author":"J Laoukili","year":"2001","unstructured":"Laoukili J et al (2001) Il-13 alters mucociliary differentiation and ciliary beating of human respiratory epithelial cells. J Clin Invest 108(12):1817\u20131824. https:\/\/doi.org\/10.1172\/jci13557","journal-title":"J Clin Invest"},{"key":"9097_CR63","doi-asserted-by":"publisher","DOI":"10.1172\/jci171268","author":"L Lei","year":"2023","unstructured":"Lei L et al (2023) CFTR-rich ionocytes mediate chloride absorption across airway epithelia. J Clin Invest. https:\/\/doi.org\/10.1172\/jci171268","journal-title":"J Clin Invest"},{"issue":"4","key":"9097_CR64","doi-asserted-by":"publisher","first-page":"367","DOI":"10.4168\/aair.2015.7.4.367","volume":"7","author":"Y Zhang","year":"2015","unstructured":"Zhang Y et al (2015) TMEM16A-mediated mucin secretion in IL-13-induced nasal epithelial cells from chronic rhinosinusitis patients. Allergy Asthma Immunol Res 7(4):367\u2013375. https:\/\/doi.org\/10.4168\/aair.2015.7.4.367","journal-title":"Allergy Asthma Immunol Res"},{"issue":"23","key":"9097_CR65","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1056\/NEJMra0910061","volume":"363","author":"JV Fahy","year":"2010","unstructured":"Fahy JV, Dickey BF (2010) Airway mucus function and dysfunction. N Engl J Med 363(23):2233\u20132247. https:\/\/doi.org\/10.1056\/NEJMra0910061","journal-title":"N Engl J Med"},{"issue":"6","key":"9097_CR66","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1002\/alr.22723","volume":"11","author":"N Khurana","year":"2021","unstructured":"Khurana N et al (2021) Inflammation-driven vascular dysregulation in chronic rhinosinusitis. Int Forum Allergy Rhinol 11(6):976\u2013983. https:\/\/doi.org\/10.1002\/alr.22723","journal-title":"Int Forum Allergy Rhinol"},{"issue":"8","key":"9097_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.112964","volume":"42","author":"H Li","year":"2023","unstructured":"Li H et al (2023) Type 2 cytokines promote angiogenesis in ischemic muscle via endothelial IL-4R\u03b1 signaling. Cell Rep 42(8):112964. https:\/\/doi.org\/10.1016\/j.celrep.2023.112964","journal-title":"Cell Rep"},{"issue":"2","key":"9097_CR68","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.jaci.2019.10.031","volume":"145","author":"A Korde","year":"2020","unstructured":"Korde A et al (2020) An endothelial microrna-1-regulated network controls eosinophil trafficking in asthma and chronic rhinosinusitis. J Allergy Clin Immunol 145(2):550\u2013562. https:\/\/doi.org\/10.1016\/j.jaci.2019.10.031","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"9097_CR69","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1067\/mai.2001.113760","volume":"107","author":"M Kraft","year":"2001","unstructured":"Kraft M et al (2001) IL-4, IL-13, and dexamethasone augment fibroblast proliferation in asthma. J Allergy Clin Immunol 107(4):602\u2013606. https:\/\/doi.org\/10.1067\/mai.2001.113760","journal-title":"J Allergy Clin Immunol"},{"issue":"38","key":"9097_CR70","doi-asserted-by":"publisher","first-page":"14646","DOI":"10.1074\/jbc.ra117.001364","volume":"293","author":"Y Mitamura","year":"2018","unstructured":"Mitamura Y et al (2018) Hierarchical control of interleukin 13 (IL-13) signals in lung fibroblasts by STAT6 and SOX11. J Biol Chem 293(38):14646\u201314658. https:\/\/doi.org\/10.1074\/jbc.ra117.001364","journal-title":"J Biol Chem"},{"issue":"3","key":"9097_CR71","first-page":"235","volume":"45","author":"K Yoshifuku","year":"2007","unstructured":"Yoshifuku K et al (2007) IL-4 and TNF-alpha increased the secretion of eotaxin from cultured fibroblasts of nasal polyps with eosinophil infiltration. Rhinology 45(3):235\u2013241","journal-title":"Rhinology"},{"issue":"8","key":"9097_CR72","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1111\/all.13395","volume":"73","author":"J Lv","year":"2018","unstructured":"Lv J et al (2018) IL-37 inhibits IL-4\/IL-13-induced CCL11 production and lung eosinophilia in murine allergic asthma. Allergy 73(8):1642\u20131652. https:\/\/doi.org\/10.1111\/all.13395","journal-title":"Allergy"},{"issue":"5","key":"9097_CR73","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1016\/j.jaci.2019.06.037","volume":"144","author":"Z Li","year":"2019","unstructured":"Li Z et al (2019) 15-Lipoxygenase 1 in nasal polyps promotes CCL26\/eotaxin 3 expression through extracellular signal-regulated kinase activation. J Allergy Clin Immunol 144(5):1228-1241.e9. https:\/\/doi.org\/10.1016\/j.jaci.2019.06.037","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"9097_CR74","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.jaci.2021.03.024","volume":"148","author":"T Delemarre","year":"2021","unstructured":"Delemarre T et al (2021) Rethinking neutrophils and eosinophils in chronic rhinosinusitis. J Allergy Clin Immunol 148(2):327\u2013335. https:\/\/doi.org\/10.1016\/j.jaci.2021.03.024","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"9097_CR75","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.alit.2019.07.002","volume":"68","author":"S Fujieda","year":"2019","unstructured":"Fujieda S et al (2019) Eosinophilic chronic rhinosinusitis. Allergol Int 68(4):403\u2013412. https:\/\/doi.org\/10.1016\/j.alit.2019.07.002","journal-title":"Allergol Int"},{"issue":"5","key":"9097_CR76","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1111\/all.12593","volume":"70","author":"D Kaur","year":"2015","unstructured":"Kaur D et al (2015) IL-33 drives airway hyper-responsiveness through IL-13-mediated mast cell: airway smooth muscle crosstalk. Allergy 70(5):556\u2013567. https:\/\/doi.org\/10.1111\/all.12593","journal-title":"Allergy"},{"issue":"4","key":"9097_CR77","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1016\/j.jaci.2021.08.019","volume":"149","author":"E M\u00e9ndez-Enr\u00edquez","year":"2022","unstructured":"M\u00e9ndez-Enr\u00edquez E et al (2022) IgE cross-linking induces activation of human and mouse mast cell progenitors. J Allergy Clin Immunol 149(4):1458\u20131463. https:\/\/doi.org\/10.1016\/j.jaci.2021.08.019","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"9097_CR78","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1016\/j.jaci.2006.02.039","volume":"117","author":"P Bradding","year":"2006","unstructured":"Bradding P, Walls A, Holgate S (2006) The role of the mast cell in the pathophysiology of asthma. J Allergy Clin Immunol 117(6):1277\u20131284. https:\/\/doi.org\/10.1016\/j.jaci.2006.02.039","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"9097_CR79","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1016\/j.jaci.2018.07.025","volume":"142","author":"G-T Zhai","year":"2018","unstructured":"Zhai G-T et al (2018) IgD-activated mast cells induce IgE synthesis in B cells in nasal polyps. J Allergy Clin Immunol 142(5):1489-1499.e23. https:\/\/doi.org\/10.1016\/j.jaci.2018.07.025","journal-title":"J Allergy Clin Immunol"},{"key":"9097_CR80","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1380846","author":"J Zhou","year":"2024","unstructured":"Zhou J et al (2024) The oxidant-antioxidant imbalance was involved in the pathogenesis of chronic rhinosinusitis with nasal polyps. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2024.1380846","journal-title":"Front Immunol"},{"key":"9097_CR81","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.110554","volume":"121","author":"J Chen","year":"2023","unstructured":"Chen J et al (2023) Inhibition of IL-4\/STAT6\/IRF4 signaling reduces the epithelial-mesenchymal transition in eosinophilic chronic rhinosinusitis with nasal polyps. Int Immunopharmacol 121:110554. https:\/\/doi.org\/10.1016\/j.intimp.2023.110554","journal-title":"Int Immunopharmacol"},{"issue":"4","key":"9097_CR82","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/j.immuni.2016.09.016","volume":"45","author":"SC-C Huang","year":"2016","unstructured":"Huang SC-C et al (2016) Metabolic reprogramming mediated by the mTORC2-IRF4 signaling axis is essential for macrophage alternative activation. Immunity 45(4):817\u2013830. https:\/\/doi.org\/10.1016\/j.immuni.2016.09.016","journal-title":"Immunity"},{"key":"9097_CR83","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2024.04.019","author":"C Liu","year":"2024","unstructured":"Liu C et al (2024) ALOX15+ M2 macrophages contribute to epithelial remodeling in eosinophilic chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol. https:\/\/doi.org\/10.1016\/j.jaci.2024.04.019","journal-title":"J Allergy Clin Immunol"},{"issue":"10","key":"9097_CR84","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1002\/alr.21984","volume":"7","author":"Y Yao","year":"2017","unstructured":"Yao Y et al (2017) Increased expression of TIPE2 in alternatively activated macrophages is associated with eosinophilic inflammation and disease severity in chronic rhinosinusitis with nasal polyps. Int Forum Allergy Rhinol 7(10):963\u2013972. https:\/\/doi.org\/10.1002\/alr.21984","journal-title":"Int Forum Allergy Rhinol"},{"key":"9097_CR85","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2021.07.045","author":"P Gevaert","year":"2021","unstructured":"Gevaert P et al (2021) Long-term efficacy and safety of omalizumab for nasal polyposis in an open-label extension study. J Allergy Clin Immunol. https:\/\/doi.org\/10.1016\/j.jaci.2021.07.045","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"9097_CR86","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.1084\/jem.178.6.2213","volume":"178","author":"G Aversa","year":"1993","unstructured":"Aversa G et al (1993) An interleukin 4 (IL-4) mutant protein inhibits both IL-4 or IL-13-induced human immunoglobulin G4 (IgG4) and IgE synthesis and B cell proliferation: support for a common component shared by IL-4 and IL-13 receptors. J Exp Med 178(6):2213\u20132218","journal-title":"J Exp Med"},{"key":"9097_CR87","doi-asserted-by":"publisher","unstructured":"Kariyawasam HH, James LK, Gane SB (2020) Dupilumab: clinical efficacy of blocking IL-4\/IL-13 signalling in chronic rhinosinusitis with nasal polyps. Drug Des Dev Ther 14:1757\u20131769. https:\/\/doi.org\/10.2147\/dddt.s243053","DOI":"10.2147\/dddt.s243053"},{"key":"9097_CR88","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.762390","author":"Z Song","year":"2022","unstructured":"Song Z et al (2022) B cell IL-4 drives Th2 responses in vivo, ameliorates allograft rejection, and promotes allergic airway disease. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2022.762390","journal-title":"Front Immunol"},{"issue":"1","key":"9097_CR89","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.cyto.2015.05.010","volume":"75","author":"J Zhu","year":"2015","unstructured":"Zhu J (2015) T helper 2 (Th2) cell differentiation, type 2 innate lymphoid cell (ILC2) development and regulation of interleukin-4 (IL-4) and IL-13 production. Cytokine 75(1):14\u201324. https:\/\/doi.org\/10.1016\/j.cyto.2015.05.010","journal-title":"Cytokine"},{"issue":"1","key":"9097_CR90","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/cea.13491","volume":"50","author":"H Harb","year":"2020","unstructured":"Harb H, Chatila TA (2020) Mechanisms of dupilumab. Clin Exp Allergy 50(1):5\u201314. https:\/\/doi.org\/10.1111\/cea.13491","journal-title":"Clin Exp Allergy"},{"issue":"1","key":"9097_CR91","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1002\/eer3.5","volume":"1","author":"Z Zhu","year":"2024","unstructured":"Zhu Z, Zhao C, Wang M (2024) IL-4\/IL-13 pathway in nasal type 2 inflammation: the central role and targeted therapy. Eye & ENT Research 1(1):39\u201348. https:\/\/doi.org\/10.1002\/eer3.5","journal-title":"Eye & ENT Research"},{"issue":"5","key":"9097_CR92","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1016\/j.jaci.2019.06.023","volume":"144","author":"M Wang","year":"2019","unstructured":"Wang M et al (2019) Cross-talk between TH2 and TH17 pathways in patients with chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol 144(5):1254\u20131264. https:\/\/doi.org\/10.1016\/j.jaci.2019.06.023","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"9097_CR93","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1038\/mi.2015.110","volume":"9","author":"UM Zissler","year":"2016","unstructured":"Zissler UM et al (2016) Interleukin-4 and interferon-gamma orchestrate an epithelial polarization in the airways. MUCOSAL IMMUNOLOGY 9(4):917\u2013926. https:\/\/doi.org\/10.1038\/mi.2015.110","journal-title":"MUCOSAL IMMUNOLOGY"},{"issue":"2","key":"9097_CR94","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/nri2487","volume":"9","author":"CB Wilson","year":"2009","unstructured":"Wilson CB, Rowell E, Sekimata M (2009) Epigenetic control of T-helper-cell differentiation. Nat Rev Immunol 9(2):91\u2013105. https:\/\/doi.org\/10.1038\/nri2487","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"9097_CR95","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.jaci.2009.01.003","volume":"123","author":"CC Lewis","year":"2009","unstructured":"Lewis CC et al (2009) Unique and overlapping gene expression patterns driven by IL-4 and IL-13 in the mouse lung. J Allergy Clin Immunol 123(4):795-804.e8. https:\/\/doi.org\/10.1016\/j.jaci.2009.01.003","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"9097_CR96","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1038\/nm.2754","volume":"18","author":"CA Akdis","year":"2012","unstructured":"Akdis CA (2012) Therapies for allergic inflammation: refining strategies to induce tolerance. Nat Med 18(5):736\u2013749. https:\/\/doi.org\/10.1038\/nm.2754","journal-title":"Nat Med"},{"issue":"7","key":"9097_CR97","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/s2213-2600(18)30201-7","volume":"6","author":"RJ Russell","year":"2018","unstructured":"Russell RJ et al (2018) Effect of tralokinumab, an interleukin-13 neutralising monoclonal antibody, on eosinophilic airway inflammation in uncontrolled moderate-to-severe asthma (MESOS): a multicentre, double-blind, randomised, placebo-controlled phase 2 trial. Lancet Respir Med 6(7):499\u2013510. https:\/\/doi.org\/10.1016\/s2213-2600(18)30201-7","journal-title":"Lancet Respir Med"},{"issue":"10","key":"9097_CR98","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/S2213-2600(16)30265-X","volume":"4","author":"NA Hanania","year":"2016","unstructured":"Hanania NA et al (2016) Efficacy and safety of lebrikizumab in patients with uncontrolled asthma (LAVOLTA I and LAVOLTA II): replicate, phase 3, randomised, double-blind, placebo-controlled trials. Lancet Respir Med 4(10):781\u2013796. https:\/\/doi.org\/10.1016\/S2213-2600(16)30265-X","journal-title":"Lancet Respir Med"},{"key":"9097_CR99","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-39311-2","author":"L Zhang","year":"2023","unstructured":"Zhang L et al (2023) Preclinical immunological characterization of rademikibart (CBP-201), a next-generation human monoclonal antibody targeting IL-4R\u03b1, for the treatment of Th2 inflammatory diseases. Sci Rep. https:\/\/doi.org\/10.1038\/s41598-023-39311-2","journal-title":"Sci Rep"},{"issue":"10209","key":"9097_CR100","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1016\/S0140-6736(19)31881-1","volume":"394","author":"C Bachert","year":"2019","unstructured":"Bachert C et al (2019) Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials. Lancet 394(10209):1638\u20131650. https:\/\/doi.org\/10.1016\/S0140-6736(19)31881-1","journal-title":"Lancet"},{"key":"9097_CR101","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2023.102076","volume":"61","author":"Y Zhang","year":"2023","unstructured":"Zhang Y et al (2023) Efficacy and safety of CM310 in severe eosinophilic chronic rhinosinusitis with nasal polyps (CROWNS-1): a multicentre, randomised, double-blind, placebo-controlled phase 2 clinical trial. EClinicalMedicine 61:102076. https:\/\/doi.org\/10.1016\/j.eclinm.2023.102076","journal-title":"EClinicalMedicine"},{"issue":"5","key":"9097_CR102","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1016\/j.jaci.2025.01.034","volume":"155","author":"M Zheng","year":"2025","unstructured":"Zheng M et al (2025) Efficacy and safety of GR1802 in uncontrolled chronic rhinosinusitis with nasal polyps: placebo-controlled phase 2 trial. J Allergy Clin Immunol 155(5):1575\u20131583. https:\/\/doi.org\/10.1016\/j.jaci.2025.01.034","journal-title":"J Allergy Clin Immunol"},{"key":"9097_CR103","doi-asserted-by":"publisher","DOI":"10.1111\/all.15134","author":"RJL van der Lans","year":"2021","unstructured":"van der Lans RJL et al (2021) Real-life observational cohort verifies high efficacy of dupilumab for chronic rhinosinusitis with nasal polyps. Allergy. https:\/\/doi.org\/10.1111\/all.15134","journal-title":"Allergy"},{"key":"9097_CR104","doi-asserted-by":"publisher","DOI":"10.1016\/j.anai.2021.01.012","author":"TM Laidlaw","year":"2021","unstructured":"Laidlaw TM et al (2021) Dupilumab improves upper- and lower-airway disease control in chronic rhinosinusitis with nasal polyps and asthma. Ann Allergy Asthma Immunol. https:\/\/doi.org\/10.1016\/j.anai.2021.01.012","journal-title":"Ann Allergy Asthma Immunol"},{"key":"9097_CR105","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2022.02.026","author":"GW Canonica","year":"2022","unstructured":"Canonica GW et al (2022) Dupilumab demonstrates rapid onset of response across three type 2 inflammatory diseases. The Journal of Allergy and Clinical Immunology: In Practice. https:\/\/doi.org\/10.1016\/j.jaip.2022.02.026","journal-title":"The Journal of Allergy and Clinical Immunology: In Practice"},{"issue":"1","key":"9097_CR106","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1111\/all.14906","volume":"77","author":"S Fujieda","year":"2022","unstructured":"Fujieda S et al (2022) Dupilumab efficacy in chronic rhinosinusitis with nasal polyps from SINUS-52 is unaffected by eosinophilic status. Allergy 77(1):186\u2013196. https:\/\/doi.org\/10.1111\/all.14906","journal-title":"Allergy"},{"key":"9097_CR107","doi-asserted-by":"publisher","DOI":"10.1111\/cea.13954","author":"JD Hamilton","year":"2021","unstructured":"Hamilton JD et al (2021) Dupilumab suppresses type 2 inflammatory biomarkers across multiple atopic, allergic diseases. Clin Exp Allergy. https:\/\/doi.org\/10.1111\/cea.13954","journal-title":"Clin Exp Allergy"},{"issue":"1","key":"9097_CR108","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.jaip.2024.09.013","volume":"13","author":"SH Li","year":"2025","unstructured":"Li SH et al (2025) Eosinophilia and adverse effects of dupilumab for respiratory indications: a real-world setting. The Journal of Allergy and Clinical Immunology: In Practice 13(1):121\u2013131. https:\/\/doi.org\/10.1016\/j.jaip.2024.09.013","journal-title":"The Journal of Allergy and Clinical Immunology: In Practice"},{"issue":"0","key":"9097_CR109","doi-asserted-by":"publisher","first-page":"0","DOI":"10.4193\/rhin24.528","volume":"0","author":"M Lazzeroni","year":"2025","unstructured":"Lazzeroni M et al (2025) Eosinophilic complications during dupilumab therapy for type 2 diseases: a systematic review. Rhinology 0(0):0\u20130. https:\/\/doi.org\/10.4193\/rhin24.528","journal-title":"Rhinology"},{"issue":"10","key":"9097_CR110","doi-asserted-by":"publisher","first-page":"2712","DOI":"10.1111\/all.15844","volume":"78","author":"FS Ryser","year":"2023","unstructured":"Ryser FS et al (2023) Dupilumab-induced eosinophilia in patients with diffuse type 2 chronic rhinosinusitis. Allergy 78(10):2712\u20132723. https:\/\/doi.org\/10.1111\/all.15844","journal-title":"Allergy"},{"issue":"1\u20132","key":"9097_CR111","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1080\/14712598.2024.2304556","volume":"24","author":"M Caminati","year":"2024","unstructured":"Caminati M et al (2024) Safety of dupilumab in T2 airways conditions: focus on eosinophilia across trials and real-life evidence. Expert Opin Biol Ther 24(1\u20132):15\u201323. https:\/\/doi.org\/10.1080\/14712598.2024.2304556","journal-title":"Expert Opin Biol Ther"},{"issue":"2","key":"9097_CR112","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1111\/all.15934","volume":"79","author":"M Caminati","year":"2024","unstructured":"Caminati M et al (2024) Eosinophilic granulomatosis with polyangiitis onset in severe asthma patients on monoclonal antibodies targeting type 2 inflammation: report from the European EGPA study group. Allergy 79(2):516\u2013519. https:\/\/doi.org\/10.1111\/all.15934","journal-title":"Allergy"},{"issue":"3","key":"9097_CR113","doi-asserted-by":"publisher","first-page":"165","DOI":"10.18176\/jiaci.0823","volume":"32","author":"J Olaguibel","year":"2022","unstructured":"Olaguibel J et al (2022) Eosinophilia induced by blocking the IL-4\/IL-13 pathway: potential mechanisms and clinical outcomes. J Investig Allergol Clin Immunol 32(3):165\u2013180. https:\/\/doi.org\/10.18176\/jiaci.0823","journal-title":"J Investig Allergol Clin Immunol"},{"key":"9097_CR114","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2023.11.924","author":"JI Silverberg","year":"2024","unstructured":"Silverberg JI et al (2024) Efficacy and safety of rademikibart (CBP-201), a next-generation mAb targeting IL-4R\u03b1, in adults with moderate to severe atopic dermatitis: a phase 2 randomized trial (CBP-201-WW001). J Allergy Clin Immunol. https:\/\/doi.org\/10.1016\/j.jaci.2023.11.924","journal-title":"J Allergy Clin Immunol"},{"key":"9097_CR115","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2024.110721","author":"W Liu","year":"2024","unstructured":"Liu W et al (2024) Stapokibart (CM310) targets IL-4R\u03b1 for the treatment of type 2 inflammation. iScience. https:\/\/doi.org\/10.1016\/j.isci.2024.110721","journal-title":"iScience"},{"key":"9097_CR116","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-84151-3","author":"FS Gillesberg","year":"2025","unstructured":"Gillesberg FS et al (2025) Regulation of fibronectin and collagens type I, III and VI by TNF-\u03b1, TGF-\u03b2, IL-13, and tofacitinib. Sci Rep. https:\/\/doi.org\/10.1038\/s41598-024-84151-3","journal-title":"Sci Rep"},{"issue":"9","key":"9097_CR117","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1001\/jamadermatol.2021.3023","volume":"157","author":"A Blauvelt","year":"2021","unstructured":"Blauvelt A et al (2021) Efficacy and safety of upadacitinib vs dupilumab in adults with moderate-to-severe atopic dermatitis. JAMA Dermatol 157(9):1047. https:\/\/doi.org\/10.1001\/jamadermatol.2021.3023","journal-title":"JAMA Dermatol"},{"issue":"5646","key":"9097_CR118","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1126\/science.1087061","volume":"302","author":"PS Changelian","year":"2003","unstructured":"Changelian PS et al (2003) Prevention of organ allograft rejection by a specific Janus kinase 3 inhibitor. Science 302(5646):875\u2013878","journal-title":"Science"},{"key":"9097_CR119","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1443704","author":"R Poto","year":"2024","unstructured":"Poto R et al (2024) The JAK1\/JAK2 inhibitor ruxolitinib inhibits mediator release from human basophils and mast cells. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2024.1443704","journal-title":"Front Immunol"},{"issue":"5","key":"9097_CR120","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1007\/s13555-021-00596-8","volume":"11","author":"A Chimalakonda","year":"2021","unstructured":"Chimalakonda A et al (2021) Selectivity profile of the tyrosine kinase 2 inhibitor deucravacitinib compared with janus kinase 1\/2\/3 inhibitors. Dermatol Ther 11(5):1763\u20131776. https:\/\/doi.org\/10.1007\/s13555-021-00596-8","journal-title":"Dermatol Ther"},{"key":"9097_CR121","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abj7002","author":"S Kamerkar","year":"2022","unstructured":"Kamerkar S et al (2022) Exosome-mediated genetic reprogramming of tumor-associated macrophages by exoASO-STAT6 leads to potent monotherapy antitumor activity. Sci Adv. https:\/\/doi.org\/10.1126\/sciadv.abj7002","journal-title":"Sci Adv"},{"issue":"8","key":"9097_CR122","doi-asserted-by":"publisher","first-page":"3036","DOI":"10.1172\/jci83416","volume":"126","author":"M Hegde","year":"2016","unstructured":"Hegde M et al (2016) Tandem CAR T cells targeting HER2 and IL13R\u03b12 mitigate tumor antigen escape. J Clin Invest 126(8):3036\u20133052. https:\/\/doi.org\/10.1172\/jci83416","journal-title":"J Clin Invest"},{"issue":"5","key":"9097_CR123","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1038\/s41591-024-02893-z","volume":"30","author":"SJ Bagley","year":"2024","unstructured":"Bagley SJ et al (2024) Intrathecal bivalent CAR T cells targeting EGFR and IL13R\u03b12 in recurrent glioblastoma: phase 1 trial interim results. Nat Med 30(5):1320\u20131329. https:\/\/doi.org\/10.1038\/s41591-024-02893-z","journal-title":"Nat Med"},{"issue":"1","key":"9097_CR124","doi-asserted-by":"publisher","first-page":"522","DOI":"10.4049\/jimmunol.180.1.522","volume":"180","author":"T Zheng","year":"2008","unstructured":"Zheng T et al (2008) IL-13 receptor \u03b12 selectively inhibits IL-13-induced responses in the murine lung. J Immunol 180(1):522\u2013529. https:\/\/doi.org\/10.4049\/jimmunol.180.1.522","journal-title":"J Immunol"},{"key":"9097_CR125","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2024.10.039","author":"JL Ingram","year":"2025","unstructured":"Ingram JL et al (2025) Leptin augments IL-13-induced airway eotaxins and submucosal eosinophilia in obesity-associated asthma. J Allergy Clin Immunol. https:\/\/doi.org\/10.1016\/j.jaci.2024.10.039","journal-title":"J Allergy Clin Immunol"},{"issue":"9","key":"9097_CR126","doi-asserted-by":"publisher","first-page":"2829","DOI":"10.1111\/all.15366","volume":"77","author":"I Shilovskiy","year":"2022","unstructured":"Shilovskiy I et al (2022) Anti-inflammatory effect of siRNAs targeted IL-4 and IL-13 in a mouse model of allergic rhinitis. Allergy 77(9):2829\u20132832. https:\/\/doi.org\/10.1111\/all.15366","journal-title":"Allergy"},{"key":"9097_CR127","doi-asserted-by":"publisher","unstructured":"Wangberg H et al (2022) Appraisal of the real-world effectiveness of biologic therapies in aspirin-exacerbated respiratory disease. J Allergy Clin Immunol Pract 10(2):478\u2013484 e3. https:\/\/doi.org\/10.1016\/j.jaip.2021.09.030","DOI":"10.1016\/j.jaip.2021.09.030"},{"issue":"3","key":"9097_CR128","doi-asserted-by":"publisher","first-page":"194","DOI":"10.4193\/Rhin22.489","volume":"61","author":"WJ Fokkens","year":"2023","unstructured":"Fokkens WJ et al (2023) EPOS\/EUFOREA update on indication and evaluation of biologics in chronic rhinosinusitis with nasal polyps. Rhinology 61(3):194\u2013202. https:\/\/doi.org\/10.4193\/Rhin22.489","journal-title":"Rhinology"},{"key":"9097_CR129","doi-asserted-by":"publisher","DOI":"10.1111\/all.15507","author":"X Xu","year":"2022","unstructured":"Xu X et al (2022) Updates in biologic therapy for chronic rhinosinusitis with nasal polyps and NSAID-exacerbated respiratory disease. Allergy. https:\/\/doi.org\/10.1111\/all.15507","journal-title":"Allergy"},{"issue":"26","key":"9097_CR130","doi-asserted-by":"publisher","first-page":"2486","DOI":"10.1056\/NEJMoa1804092","volume":"378","author":"M Castro","year":"2018","unstructured":"Castro M et al (2018) Dupilumab efficacy and safety in moderate-to-severe uncontrolled asthma. N Engl J Med 378(26):2486\u20132496. https:\/\/doi.org\/10.1056\/NEJMoa1804092","journal-title":"N Engl J Med"},{"issue":"5","key":"9097_CR131","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1016\/j.jaci.2018.03.004","volume":"141","author":"C Bachert","year":"2018","unstructured":"Bachert C et al (2018) Endotype-driven care pathways in patients with chronic rhinosinusitis. J Allergy Clin Immunol 141(5):1543\u20131551. https:\/\/doi.org\/10.1016\/j.jaci.2018.03.004","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"9097_CR132","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.jaci.2024.05.030","volume":"154","author":"K Gayvert","year":"2024","unstructured":"Gayvert K et al (2024) Nasal brushing molecular endotyping distinguishes patients with chronic rhinosinusitis with nasal polyps with better response to dupilumab. J Allergy Clin Immunol 154(3):619\u2013630. https:\/\/doi.org\/10.1016\/j.jaci.2024.05.030","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"9097_CR133","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1111\/all.15532","volume":"78","author":"MB Soyka","year":"2023","unstructured":"Soyka MB et al (2023) Predicting dupilumab treatment outcome in patients with primary diffuse type 2 chronic rhinosinusitis. Allergy 78(4):1036\u20131046. https:\/\/doi.org\/10.1111\/all.15532","journal-title":"Allergy"},{"issue":"5","key":"9097_CR134","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1136\/gutjnl-2022-327276","volume":"72","author":"M Brusilovsky","year":"2023","unstructured":"Brusilovsky M et al (2023) Vitamin D receptor and STAT6 interactome governs oesophageal epithelial barrier responses to IL-13 signalling. Gut 72(5):834\u2013845. https:\/\/doi.org\/10.1136\/gutjnl-2022-327276","journal-title":"Gut"}],"container-title":["Clinical Reviews in Allergy & Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-025-09097-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12016-025-09097-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-025-09097-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T09:32:18Z","timestamp":1758187938000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12016-025-09097-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,18]]},"references-count":134,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["9097"],"URL":"https:\/\/doi.org\/10.1007\/s12016-025-09097-4","relation":{},"ISSN":["1559-0267"],"issn-type":[{"value":"1559-0267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,18]]},"assertion":[{"value":"22 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"87"}}